# BioCorteX

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biocortex

- Industry: Biotechnology
- Headquarters: London, UK
- Website: www.biocortex.com
- Total disclosed funding: $5M
- Latest round: Seed (Oct 31, 2022)
- Investors on record: 2

## About

Based in London, UK, and founded in 2021 by co-founders Nik Sharma and Mo Alomari, BioCorteX offers a deep tech and artificial intelligence platform to simulate the colossal number of microbiotas interacting with a drug to de-risk preclinical studies and clinical trials. In October 2022, BioCorteX raised GBP 4.32 million in seed funding, co-led by Sofinnova Partners and Hoxton Ventures.

BioCorteX offers a product called Carbon Mirror that uses technology incorporating principles of physics and chemistry to create in-silico simulations with high fidelity, to assess and predict an individual's response to treatment based on their microbiome profile. The company offers a techbio platform to model the complex interactions between the microbiome, host, and treatment, which help clinicians to provide personalized treatment. The technology can utilize in pharmaceuticals, cosmetics, personal care products, industry, and agriculture.

## Funding rounds

- Seed, Oct 31, 2022, $5M — Sofinnova Partners, Hoxton Ventures

## Investors

- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Seed
- Hoxton Ventures (https://capitalatlas.ai/funds/hoxton-ventures) — Seed